anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Diagnose Problem

Slide function collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 2,245
Current window 841-870
Pages 75
Rows per page 30
Slide function: Diagnose Problemclear collectionreset all
18 30 60

Slide function

841-870 of 2,245

filter-aware
119
The slide uses a 'pull-quote' structure to validate the problem statement.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Testimonials from Customers and Former Employees1 hit
123
The slide uses direct quotes from an expert consultation to validate negative feedback regarding the product's usability and performance.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller Beat · Testimonials from Customers and Former Employees1 hit
153
The slide uses direct quotes from former employees to validate the thesis that the product is difficult to use.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller 1 hit
154
The slide uses direct quotes to validate the claim of high operational burden.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller 1 hit
28
The slide uses aggressive, activist-style language to frame the company as a 'greater fool SPAC' and 'broken business model'.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit
26
The slide uses a combination of narrative argument and a supporting table of pharmacologic approaches to justify the 'difficult' commercial landscape.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
49
Includes a process diagram showing the progression from hERG block to Torsades de Pointes.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
50
The slide uses red underlining to emphasize key risk statements, likely to draw attention to the severity of the condition in the context of a drug evaluation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · The Reveal1 hit
58
Includes a visual comparison of pharmacophore models and a specific reference to ABT-239.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal1 hit
59
The slide highlights a fundamental design constraint in medicinal chemistry.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal1 hit
60
The slide uses visual evidence to link a specific chemical moiety (piperidine) to a known safety liability (hERG blockade).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal1 hit
70
The slide uses a 'villain' framing by highlighting the industry-wide failure of a specific drug class.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
71
The slide uses a combination of chemical structure diagrams, a tabular summary of clinical trial failures, and a pie chart showing the distribution of indications for failed trials.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
74
The slide uses a combination of narrative summary and a direct excerpt from a scientific review paper to validate the difficulty of the target.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
76
The slide uses excerpts from scientific literature to frame the technical hurdles in CNS drug development.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
117
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
189
The slide presents a clinical case study analysis of a specific adverse event report (FAERS).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
190
This slide presents raw clinical case data from the FDA FAERS database to support a hypothesis about drug interactions.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
195
This is a pharmacovigilance case report summary.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
255
The slide uses a Q&A format to present qualitative feedback from a medical expert.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
261
The slide presents qualitative feedback from a medical professional, highlighting skepticism and administrative barriers.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
288
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
306
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
357
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
252
The slide argues that Lasertec's growth drivers are exhausted, citing product defects and customer dissatisfaction.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
11
The slide presents a highly critical investigative report on Lasertec's core product, alleging technical failure and financial misrepresentation.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · Problem & ComplicationLoop · Logic Chain1 hit
12
The slide uses a strong, accusatory tone, labeling the company a 'textbook Ponzi'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The MonsterLoop · The Reveal1 hit
15
The slide uses a dual-axis chart to show revenue growth vs. YOY growth rate, illustrating the 'hitting a wall' narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The MonsterLoop · The Reveal1 hit
52
The slide uses strong, accusatory language typical of activist short reports to frame the company's business model as fundamentally broken.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction1 hit
54
This is a classic activist short-seller slide designed to frame the company's business model as inherently fraudulent and legally precarious.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction1 hit